Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Particulate Matter: Particulate matter identified as glass
| Brand name | KETOROLAC TROMETHAMINE |
| Generic name | KETOROLAC TROMETHAMINE |
| Active ingredient(s) | KETOROLAC TROMETHAMINE |
| Distributed by / for | Aspiro Pharma Limited |
| NDC | 31722-307-25 |
| Full product label | Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label). |
| Recalling firm | Aspiro Pharma Limited |
| Distribution | Nationwide within the United States |
| Recall initiated | 2025-10-01 |
| Report date | 2025-10-29 |
| Recall completed | — |
| Recall number | D-0036-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Siddipet (District) India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗